ORIGINAL RESEARCH
Accepted on 28 Jul 2025
PD-1 and LAG-3 were optimal combination of immune checkpoints for predicting poor clinical outcomes of patients with ovarian cancer
doi 10.3389/fimmu.2025.1656242
- 174 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in The Immunosuppressive Tumor Microenvironment and Strategies to Revert its Immune Regulatory Milieu for Cancer Immunotherapy: Volume II
Community Series in The Immunosuppressive Tumor Microenvironment and Strategies to Revert its Immune Regulatory Milieu for Cancer Immunotherapy: Volume II
4,093
Total downloads
15k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 23 Jul 2025
Hypercholesterolemia and the role of lipid metabolism gene CES1 in immune infiltration promote central nervous system relapse in acute myeloid leukemia
doi 10.3389/fimmu.2025.1575472
- 506 views
ORIGINAL RESEARCH
Accepted on 21 Jul 2025
High stroma-tumor ratio is associated with immuno-suppressive tumor microenvironment and poor prognosis in bladder cancer
doi 10.3389/fonc.2025.1604609
- 173 views
ORIGINAL RESEARCH
Published on 16 Jul 2025
Identification of a stromal immunosuppressive barrier orchestrated by SPP1+/C1QC+ macrophages and CD8+ exhausted T cells driving gastric cancer immunotherapy resistance
doi 10.3389/fimmu.2025.1618591
- 835 views
SYSTEMATIC REVIEW
Published on 09 May 2025
Research trends on lactate in cancer: a bibliometric analysis and comprehensive review (2015–2024)
doi 10.3389/fimmu.2025.1587867
- 1,797 views
ORIGINAL RESEARCH
Published on 01 Apr 2025
Heterogeneity of γδ T-cell subsets and their clinical correlation in patients with AML
doi 10.3389/fimmu.2025.1552235
- 1,831 views
ORIGINAL RESEARCH
Published on 04 Dec 2024
Heterogeneous immune landscapes and macrophage dynamics in primary and lung metastatic adenoid cystic carcinoma of the head and neck
doi 10.3389/fimmu.2024.1483887
- 1,566 views
ORIGINAL RESEARCH
Published on 24 Sep 2024
DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways
doi 10.3389/fimmu.2024.1470328
- 2,805 views
ORIGINAL RESEARCH
Published on 21 Aug 2024
Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity
doi 10.3389/fimmu.2024.1426657
- 2,622 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore